Join us on Wednesday, 27 May 2026 at 9am EDT (New York) | 2pm BST (London) | 3pm CEST (Paris) to explore the critical factors an organization must consider when implementing AI-enabled automation.
In this webinar, the presenters will guide attendees through a practical roadmap for implementing intelligent automation into the pharma microbiology workflow. From initial planning to commercial use, this session lays the foundation for an organization to maximize value while maintaining compliance and control during the implementation process.
Overview
The session will cover the primary goals of AI-powered automation within the workflow, such as increasing throughput, reducing human error, and enhancing traceability. The practical challenges that can arise during implementation will be addressed, while also reviewing the factors that must be considered to ensure smooth operational transition and maintenance of the validated state.
In pharma microbiology, processes often span multiple functions, including QC and production, requiring alignment across diverse stakeholders such as IT, quality assurance, and operations teams. Securing early understanding, engagement, and cross-functional support is critical to successful implementation.
The webinar will conclude with a 20 minute roundtable Q&A with the presenters.
Presenters:
Dr Steven Giglio, PhD, Chief Scientific Officer, Clever Culture Systems
Bianca De Young, Microbiology Services Manager, Clever Culture Systems
Dr Chris Ramsey, PhD, Business Development Director, North America, Clever Culture Systems
Take the first step in setting your program up for success.
